about
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...
Read More
20.13
-0.23
(-1.13%)
53,815.5
XNAS Volume
XNAS 07 Apr, 2026 11:22 AM (EDT)
Board Meeting
The next board meeting for DBV Tech (ADR) is on 10 Apr 2026 for the purpose of DBV Technologies SA Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
DBV Tech (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..